MY108437A - Imidazopyridine paf/h1 antagonists - Google Patents

Imidazopyridine paf/h1 antagonists

Info

Publication number
MY108437A
MY108437A MYPI92000223A MYPI19920223A MY108437A MY 108437 A MY108437 A MY 108437A MY PI92000223 A MYPI92000223 A MY PI92000223A MY PI19920223 A MYPI19920223 A MY PI19920223A MY 108437 A MY108437 A MY 108437A
Authority
MY
Malaysia
Prior art keywords
paf
antagonists
imidazopyridine
formula
ring
Prior art date
Application number
MYPI92000223A
Other languages
English (en)
Inventor
Robert John Dr Bass
David Dr Alker
Kelvin Dr Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY108437A publication Critical patent/MY108437A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
MYPI92000223A 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists MY108437A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
MY108437A true MY108437A (en) 1996-09-30

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI92000223A MY108437A (en) 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists

Country Status (29)

Country Link
US (1) US5358953A (enExample)
EP (1) EP0572425B1 (enExample)
JP (1) JP2506541B2 (enExample)
KR (1) KR970005302B1 (enExample)
CN (1) CN1040326C (enExample)
AT (1) ATE109482T1 (enExample)
AU (1) AU650322B2 (enExample)
BR (1) BR9205615A (enExample)
CA (1) CA2099381C (enExample)
CZ (1) CZ280504B6 (enExample)
DE (1) DE69200304T2 (enExample)
DK (1) DK0572425T3 (enExample)
EG (1) EG20085A (enExample)
ES (1) ES2059212T3 (enExample)
FI (1) FI933531A7 (enExample)
GB (1) GB9102997D0 (enExample)
HU (2) HUT65947A (enExample)
IE (1) IE65125B1 (enExample)
IL (1) IL100887A (enExample)
MX (1) MX9200589A (enExample)
MY (1) MY108437A (enExample)
NO (1) NO300592B1 (enExample)
NZ (1) NZ241597A (enExample)
PL (1) PL169304B1 (enExample)
RU (1) RU2114845C1 (enExample)
TW (1) TW227000B (enExample)
WO (1) WO1992014734A1 (enExample)
YU (1) YU48238B (enExample)
ZA (1) ZA921005B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
WO1996005201A1 (en) * 1994-08-10 1996-02-22 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
EP0842175A1 (en) * 1995-08-05 1998-05-20 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
CN100553636C (zh) 2000-08-04 2009-10-28 Dmi生物科学公司 二酮基哌嗪和包含它们的组合物的使用方法
EP2517718B1 (en) 2003-05-15 2016-03-02 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
NZ587050A (en) 2008-01-30 2012-08-31 Nippon Zoki Pharmaceutical Co Compounds featuring a tricyclic group double bonded to a piperidine group, as an antihistamine
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
JP5978296B2 (ja) * 2011-06-28 2016-08-24 フジアン・ミンドン・レジュヴネイション・ファーマスーティカル・カンパニー・リミテッド 抗アレルギ性ベンゾシクロヘプタチオフェン誘導体
MY172699A (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EA028343B1 (ru) 2011-10-10 2017-11-30 Ампио Фармасьютикалз, Инк. Лечение дегенеративного заболевания сустава
EP2771007B1 (en) * 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
RU2736513C2 (ru) 2014-08-18 2020-11-17 Ампио Фармасьютикалз, Инк. Лечение патологических состояний суставов
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (enExample) * 1963-04-24
EP0404797B1 (en) * 1988-03-15 1995-02-01 G.D. Searle & Co. 1H/3H-[4-(N,N-CYCLOALKYL AND/OR BRANCHED-ALKYLCARBOXAMIDO) -BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
MY106964A (en) * 1988-04-28 1995-08-30 Schering Corp Fused polycyclic compounds, compositions, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents.
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
JPH0678340B2 (ja) * 1990-05-09 1994-10-05 フアイザー・インコーポレイテツド 喘息、関節炎および関連疾患の治療におけるアザベンジミダゾール

Also Published As

Publication number Publication date
NO932889L (no) 1993-08-13
ES2059212T3 (es) 1994-11-01
ZA921005B (en) 1993-08-12
WO1992014734A1 (en) 1992-09-03
NZ241597A (en) 1993-04-28
AU650322B2 (en) 1994-06-16
IL100887A (en) 1996-01-19
AU1168392A (en) 1992-09-15
EG20085A (en) 1997-05-31
YU14392A (sh) 1994-11-15
GB9102997D0 (en) 1991-03-27
FI933531L (fi) 1993-08-10
PL169304B1 (pl) 1996-06-28
TW227000B (enExample) 1994-07-21
JP2506541B2 (ja) 1996-06-12
NO932889D0 (no) 1993-08-13
DE69200304T2 (de) 1994-12-08
CN1064275A (zh) 1992-09-09
KR970005302B1 (ko) 1997-04-15
BR9205615A (pt) 1994-05-17
HU211202A9 (en) 1995-11-28
RU2114845C1 (ru) 1998-07-10
IL100887A0 (en) 1992-11-15
IE920449A1 (en) 1992-08-12
IE65125B1 (en) 1995-10-04
MX9200589A (es) 1992-10-01
HUT65947A (en) 1994-08-29
EP0572425B1 (en) 1994-08-03
EP0572425A1 (en) 1993-12-08
CA2099381A1 (en) 1992-08-14
FI933531A0 (fi) 1993-08-10
FI933531A7 (fi) 1993-08-10
JPH06504992A (ja) 1994-06-09
CA2099381C (en) 1996-07-09
NO300592B1 (no) 1997-06-23
CN1040326C (zh) 1998-10-21
DK0572425T3 (da) 1994-09-12
US5358953A (en) 1994-10-25
YU48238B (sh) 1997-08-22
CZ280504B6 (cs) 1996-02-14
HU9302327D0 (en) 1993-10-28
DE69200304D1 (de) 1994-09-08
CS42592A3 (en) 1992-09-16
ATE109482T1 (de) 1994-08-15

Similar Documents

Publication Publication Date Title
MY108437A (en) Imidazopyridine paf/h1 antagonists
UA26427A (uk) Похідhі ксаhтиhу у вигляді суміші ізомерів або іhдивідуальhих ізомерів, що мають властивість аhтагоhіста адеhозиhу
HRP950482B1 (en) SYNTHESIS OF 3-(4-(2-AMINOETOXY)BENZOYL)-ARYL-6-HYDROXYBENZO(b)THIOPHENE
YU82304A (sh) Kristalni 3,4,4-trisupstituisani-piperidinil-n-alkilkarboksilati, intermedijeri i postupak za dobijanje
ES2167371T3 (es) Derivados de 1h-3-aril-pirrolidin-2,4-diona espirociclicos substituidos.
ATE233559T1 (de) Verwendung von benzothiophene zur behandlung von hypercholesterolämie
IL69912A (en) Substituted 1-hydroxyethyltriazolyl derivatives,their preparation and their use as plant protection agents
UA41290C2 (uk) Гетероариламіни, фармацевтична композиція, спосіб інгібування холінестерази у ссавців, спосіб покращення пам'яті
GR3005072T3 (enExample)
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
DK37580A (da) 4,5-dihydro-4-oxofuran-2-carboxylsyrederivater samt deres fremstilling og anvendelse
YU46589B (sh) Smeše kaučuka koje se mogu vulkanizovati
AU564799B2 (en) Composition for prophylactic and preventative of ketosis in livestock
SE8406338L (sv) 4,5,6,7-tetrahydrotiazolo/5,4-c/-pyridinderivat
ES2062568T3 (es) Nuevos derivados de benzo (b) fenantrolinas-1,7 su preparacion y su aplicacion en terapeutica.
IE830686L (en) 1,2,5-thiadiazoles
IL62226A0 (en) Cephalosporins,their preparation and pharmaceutical compositions containing them
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
ES8505653A1 (es) Procedimiento para preparar un n-alquil-(3 o 4)piperidinil benzoato
MY103521A (en) Bicyclocatechol derivatives
DE3465995D1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof
DE69001794D1 (de) Phenothiazinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
PH15866A (en) Substituted 4-amino 2,6-diaryl-tetrahydrothiopyrans and salts thereof,and use as antidepressants